MEDICATION COST IMPLICATION FOR THE MANAGEMENT OF HYPERTENSION AND DIABETES IN NIGER DELTA- TERTIARY HOSPITAL BASED STUDY IN BAYELSA STATE, NIGERIA

Author(s)

Ganiyu KA1, Erah PO2
1Niger Delta University, Wilberforce Island, Bayelsa State, Nigeria, 2University of Benin, Benin City, Nigeria

OBJECTIVES: To assess the economic burden of the management of hypertension and diabetes in two tertiary health facilities in Bayelsa State, Niger Delta, South-south Nigeria. METHODS: It is a retrospective review of randomly selected case notes of 531 hypertensive and diabetic patients. The demographics and cost of medicines prescribed were reviewed based on the hospital prices. These patients were randomly selected from those who attended the endocrinology and cardiology clinics of the health facilities in 2011 and 2012. RESULTS: Mean patients’ age was 55.70±12.23 years.  Most (42.2%) of them were civil servants while the rest were petty business owners (26.6%), retired workers (14.9%), farmers (10.3%), or unemployed (6%). The monthly average costs of all prescribed medications per patient for initiation and maintenance of therapy were ₦3333.43±

Conference/Value in Health Info

2015-05, ISPOR 2015, Philadelphia, PA, USA

Value in Health, Vol. 18, No. 3 (May 2015)

Code

PCV51

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies, Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Cardiovascular Disorders, Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×